Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#4570 Diagnosis of carcinoid heart disease continues to be late delayed
Introduction: Carcinoid heart disease (CHD) is a serious complication of neuroendocrine tumours. It affects patients with carcinoid syndrome and results from fibrotic deposits on the heart valves. It significantly impacts patient prognosis.
Conference:
Presenting Author:
Authors: Sharma J, Shah T, Coldham C, Vickrage S, Rehman Z,
Keywords: carcinoid syndrome, neuroendocrine tumour, carcinoid heart disease, symptoms, presentation, echocardiogram, heart valves,
#4537 The usefulness of circulating fibrosis markers in detection of carcinoid heart disease
Introduction: Carcinoid heart disease (CHD) is a potential serious fibrotic complication in patients with neuroendocrine neoplasms (NENs), affecting the heart valves. Early detection is crucial to avoid severe manifestations. NT-proBNP is suggested as an initial screening tool in detection of CHD; however, the value of NT-proBNP as a screening tool is questionable.
Conference:
Presenting Author: Lau T
Authors: Lau T, Angeli E, Oksjoki R, Rasmussen V, Genovese F,
Keywords: carcinoid heart disease, biomarker, fibrosis marker,
#4152 Valvular surgery in carcinoid heart disease – Indications and outcome
Introduction: Neuroendocrine tumors (NET) can release biogenic amines that can induce a fibrotic process in the heart valves known as carcinoid heart disease (CHD). Valvular replacement surgery is the standard of care, but such interventions are associated with significant morbidity and valid criteria for both selecting patients (pts) and timing of surgery are limited.
Conference:
Presenting Author:
Authors: Sponheim J, Beitnes J, Dahle G, Åvitsland T, Thiis-Evensen E,
Keywords: carcinoid heart disease, valvular surgery, prognostic factors,
#3313 Carcinoid heart surgery: Review of outcomes from a single large centre
Introduction: Up to half of patients with carcinoid syndrome develop carcinoid heart disease and valve degeneration can lead to right heart failure. Surgical replacement of affected valves is an effective therapy. Peptide receptor radio-targeted therapy (PRRT) has demonstrated better progression-free survival compared to high dose sandostatin LAR.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author: Maclean R
Authors: Maclean R, Cope J, Hota S, Mulholland N, Ramage J,
Keywords: PRRT, Lutetium, Lutathera, carcinoid syndrome, valve replacement,